CRISPR/Cas9 Genome Editing for Tissue‐Specific In Vivo Targeting: Nanomaterials and Translational Perspective
Deepak Kumar Sahel, Lalitkumar K. Vora, Aishwarya Saraswat, Saurabh Sharma, Jasmin Monpara, Anisha D’Souza, Deepakkumar Mishra, Kamatham Pushpa Tryphena, Satoru Kawakita, Shahid Khan, Mohd Azhar, Dharmendra Kumar Khatri, Ketan Patel, Raghu Raj Singh Thakur
Abstract
In the original published article, Satoru Kawakita and Shahid Khan affiliations are swapped. Please find below the correct affiliations.<br/><br/>D. K. Sahel<br/>Department of Pharmacy<br/>Birla Institute of Technology and Science-Pilani<br/>BITS-Pilani, Vidya Vihar, Pilani, Rajasthan 333031, India<br/><br/>L. K. Vora, D. Mishra, R. R. Singh Thakur<br/>School of Pharmacy<br/>Queen's University Belfast<br/>97 Lisburn Road, Belfast BT9 7BL, UK<br/>E-mail: [email protected]<br/><br/>A. Saraswat, K. Patel<br/>College of Pharmacy & Health Sciences<br/>St. John's University<br/>Queens, NY11439, USA<br/><br/>S. Sharma, S. Kawakita<br/>Terasaki Institute for Biomedical Innovation<br/>Los Angeles, CA 90064, USA<br/><br/>J. Monpara<br/>Department of Pharmaceutical Sciences<br/>University of Sciences<br/>Philadelphia, PA 19104, USA<br/><br/>A. A. D'Souza<br/>Graduate School of Pharmaceutical Sciences and School of Pharmacy<br/>Duquesne University<br/>Pittsburgh, PA 15282, USA<br/><br/>K. P. Tryphena, D. K. Khatri<br/>Molecular and Cellular Neuroscience Lab<br/>Department of Pharmacology and Toxicology<br/>National Institute of Pharmaceutical Education and Research<br/>(NIPER)-HyderabadTelangana 500037, India<br/>E-mail: [email protected]<br/><br/>S. Khan<br/>Department of Biomedical Engineering<br/>University of California<br/>Davis, CA 95616, USA<br/><br/>M. Azhar<br/>Research and Development Tata Medical and Diagnostics Limited<br/>Mumbai, Maharashtra 400001, India<br/><br/>